HomeEVG • LON
Follow
Evgen Pharma PLC
Previous close
GBX 0.88
Day range
GBX 0.85 - GBX 0.90
Year range
GBX 0.81 - GBX 4.05
Market cap
2.32M GBP
Avg Volume
1.35M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
.INX
0.11%
Financials
Income Statement
Revenue
Net income
(GBP) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 198.00K | — |
Operating expense | — | — |
Net income | -729.50K | 32.11% |
Net profit margin | -368.43 | — |
Earnings per share | — | — |
EBITDA | -726.50K | 34.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.73M | -48.03% |
Total assets | 4.35M | -42.54% |
Total liabilities | 415.00K | -4.38% |
Total equity | 3.94M | — |
Shares outstanding | 274.89M | — |
Price to book | 0.88 | — |
Return on assets | -41.93% | — |
Return on capital | -46.35% | — |
Cash Flow
Net change in cash
(GBP) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -729.50K | 32.11% |
Cash from operations | -636.00K | 32.27% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -636.00K | 31.50% |
Free cash flow | -426.44K | 35.57% |
About
Founded
2014
Website
Employees
10